Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,860,985
+$239,114 QoQ
Shares Held
19,140
+1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#1,637
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. JNJ ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,860,985 | 19,140 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,621,871 | 18,908 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,735,033 | 18,048 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,433,978 | 18,520 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $2,698,939 | 17,669 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,914,140 | 17,572 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,458,106 | 16,997 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,748,537 | 16,960 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,452,418 | 16,779 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,583,242 | 16,330 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,875,238 | 18,344 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,798,983 | 17,971 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,501,575 | 21,155 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,688,380 | 23,796 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,715,479 | 21,033 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,410,140 | 20,875 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,737,118 | 21,053 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,847,840 | 21,711 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,582,376 | 20,941 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,497,444 | 21,656 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,992,144 | 24,233 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,444,352 | 27,042 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,808,903 | 30,556 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,694,633 | 31,533 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,401,859 | 31,301 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,654,464 | 20,243 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||